Target intelligence / Profile preview

HIV-1 replication

Molecular classification
Other (process, not molecular target)
01

Overview

“HIV-1 replication” describes the multi-step process by which Human Immunodeficiency Virus type 1 (HIV-1) infects a cell, converts its RNA genome into DNA via reverse transcriptase, integrates the DNA into the host genome using integrase, produces viral proteins and RNA by hijacking host cellular machinery, assembles new virions, and releases them from the host cell to perpetuate infection[4][6][8]. This process involves numerous viral proteins (gag, pol, env, tat, rev, nef, vif, vpr, vpu)[1][2][4], host factors, and complex viral-host interactions, and is broadly targeted by antiretroviral drugs. However, the term “HIV-1 replication” is not itself a singular molecular target and should be replaced by the specific HIV-1 gene products or host factors involved (e.g., HIV-1 reverse transcriptase, HIV-1 protease, CCR5 receptor, CXCR4 receptor) for structured biomedical records.

Other names
HIV replicationHIV-1 life cycleHIV-1 viral replication
02

Mechanism of action

Inhibition of specific steps in the viral life cycle by targeting individual HIV-1 proteins (e.g., viral polymerase, protease, integrase) or viral entry receptors.

03

Biological functions

Viral entryReverse transcriptionIntegrationTranscriptionTranslationAssemblyBudding
04

Disease associations

InfectionAIDS (Acquired Immunodeficiency Syndrome)
05

Safety considerations

Safety concerns apply to anti-HIV drugs targeting individual proteins or host factors, not to the replication process itself.
06

Interacting drugs

Drugs targeting individual HIV-1 proteins (e.g., reverse transcriptase, protease, integrase, envelope glycoproteins) or host factors
07

Biomarkers

Viral load (HIV-1 RNA)HIV-1 p24 antigen

Beyond the preview

Go deeper on HIV-1 replication.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 replication.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call